Experts Recommend Buying Gold and Silver! Barrick Mining, Newmont, First Majestic Silver, and Desert Gold in Focus

Is it time to buy gold and silver stocks again? Precious metals expert Markus Bußler, among others, believes so. According to him, the risk-reward…

The New China: Power Metallic Mines, GE Aerospace, and DHL Group See Investment Opportunities in Saudi Arabia

The FIFA World Cup has just come to an end, and the roadmap for future tournaments is already in place. The most forward-looking executives…

Things are heating up! Disappointment at Nel ASA – can A.H.T. Syngas, E.ON, and ITM Power deliver?

It is earnings season again! As is the case every year starting in mid-July, publicly traded companies are reporting on the past quarter. There…

Mercedes-Benz Dangerously Close to the Brink! BYD Posts Strong Numbers! American Atomics Offers the Solution to the Energy Crisis!

Even in July 2026, parts of the world remain in flames. We have to make sure these flames do not spread further or even…

A Renewed Flare-Up of the Iran Conflict Fuels the Oil Industry: BP, Zefiro Methane, and Shell

The renewed escalation in the Middle East is having an immediate ripple effect on the oil and gas markets. Even the mere possibility of…

Another Setback for Rheinmetall? DroneShield Sounds the Alarm as Volatus Aerospace Pushes Ahead

Is the next German-French defence project headed for failure? In an interview with Welt am Sonntag, Rheinmetall CEO Armin Papperger warns of a possible…

Gold Price Above USD 4,000 and Central Bank Rally: Barrick Mining, Lahontan Gold, Newmont—Time to Buy Now?

The gold price is holding firmly above USD 4,000, supported in part by central bank purchases. In May, Poland, China, and Chile increased their…

These Are the Leaders in a League of Their Own! Despite price surges at Almonty, Micron, and Aixtron, Is There More Upside Ahead?

Over the past 12 months, stocks in the AI, commodities, and defence sectors have, on the whole, been investor favourites. Price surges were increasingly…

Panic in the Multi-Billion-Dollar Market: Novo Nordisk and Halozyme Therapeutics Face Headwinds—BioNxt Solutions Nears a Turning Point

The global pharmaceutical market is worth hundreds of billions of dollars. Yet one of the industry's most surprising realities is that success increasingly depends…

Most Valuable Companies: Undervalued and Poised for a Turnaround? ASML, BASF, Desert Gold

Despite the wars in Ukraine and Iran, the current stock market environment remains bullish, and there are always companies emerging as promising candidates for…

The Patent Cliff Could Cost Billions: How Bayer and Merck & Co. Respond—and How Vidac Pharma Is Gaining Momentum

Leading oncology centers have long recognized that the fight against cancer cannot be won with just one active ingredient. It is increasingly clear that…